Supplementary Figure S3 from Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non–Small Cell Lung Cancer

Bruna Pellini; Russell William Madison; Merrida A. Childress; Shoshana T. Miller; Ole V. Gjoerup; Jason Cheng; Richard S.P. Huang; Michael R. Krainock; Pratyush Gupta; Wei Zou; David S. Shames; Solomon Moshkevich; Marcus Ballinger; MC Liu; Amanda G. Young; Minu K. Srivastava; Geoffrey R. Oxnard; Mark A. Socinski

doi:10.1158/1078-0432.31085014

Supplementary Figure S3 from Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non–Small Cell Lung Cancer

2026 Open access

Read full text

Authors: Bruna Pellini, Russell William Madison, Merrida A. Childress, Shoshana T. Miller, Ole V. Gjoerup, Jason Cheng, Richard S.P. Huang, Michael R. Krainock, Pratyush Gupta, Wei Zou, David S. Shames, Solomon Moshkevich

+6 more

Marcus Ballinger, MC Liu, Amanda G. Young, Minu K. Srivastava, Geoffrey R. Oxnard, Mark A. Socinski

DOI: 10.1158/1078-0432.31085014

Cited by: 0

Abstract

Supplementary Figure S3: Any ctDNA decrease or full clearance at C4D1 on chemoIO identifies patients with poorer outcomes on IO maintenance

Fields of Study & Subjects

Cancer Genomics and Diagnostics Lung Cancer Diagnosis and Treatment Lung Cancer Treatments and Mutations

Publication details

Publication date: 19 January 2026